The impact of preoperative elevated serum C-reactive protein on postoperative morbidity and mortality after anatomic resection for lung cancer

- Measurement of CRP level is a routinely performed perioperative procedure.
- CRP level is a significant prognostic factor in several malignant diseases.
- CRP level is an independent indicator for postoperative morbidity and mortality.
- CRP should be evaluated as preoperative diagnostic modality of risk assessment.

IntroductionThe aim of this study was to determine whether preoperative elevated serum C-reactive protein (CRP) is an independent risk factor of postoperative morbidity and mortality after pulmonary resection for lung cancer.Material and methodsA retrospective analysis of prospectively collected data on 1414 consecutive patients that underwent an anatomic resection for lung cancer was performed. Patients' characteristics, operative procedures and the postoperative outcome were assessed with a standardised data entry form. Univariate and multivariate analyses were conducted to identify factors that affect morbidity and mortality.ResultsPostoperative complications occurred in 35.5% of the patients. The mortality rate was 3.2%. Patients with preoperative C-reactive protein above 40 mg/l showed more overall complications and a higher mortality than patients below this limit. Patients with a CRP level between 3 mg/l and 40 mg/l had no significant increase in morbidity and mortality compared to patients with values ​​below the detection limit (< 3 mg/l).ConclusionsPreoperative serum C-reactive protein level is an independent and significant indicator for elevated morbidity and mortality after pulmonary resection. We propose the evaluation of CRP levels as a preoperative diagnostic modality of risk assessment in addition to standardised functional testing.